Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma von Campbell, Kerry S, Cohen, Adam D, Pazina, Tatiana

Volltext

Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma von Cornell, Robert F, Ky, Bonnie, Weiss, Brendan M, Dahm, Cherie N, Gupta, Deepak K, Du, Liping, Carver, Joseph R, Cohen, Adam D, Engelhardt, Brian G, Garfall, Alfred L, Goodman, Stacey A, Harrell, Shelton Lacy, Kassim, Adetola A, Jadhav, Trafina, Jagasia, Madan, Moslehi, Javid, O'Quinn, Rupal, Savona, Michael R, Slosky, David, Smith, Amanda, Stadtmauer, Edward A, Vogl, Dan T, Waxman, Adam, Lenihan, Daniel

Volltext

Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma von Shah, Jatin J., Stadtmauer, Edward A., Abonour, Rafat, Cohen, Adam D., Bensinger, William I., Gasparetto, Cristina, Kaufman, Jonathan L., Lentzsch, Suzanne, Vogl, Dan T., Gomes, Christina L., Pascucci, Natalia, Smith, David D., Orlowski, Robert Z., Durie, BrianG.M.

Volltext

Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease von Fajgenbaum, David C, Langan, Ruth-Anne, Japp, Alberto Sada, Partridge, Helen L, Pierson, Sheila K, Singh, Amrit, Arenas, Daniel J, Ruth, Jason R, Nabel, Christopher S, Stone, Katie, Okumura, Mariko, Schwarer, Anthony, Jose, Fábio Freire, Hamerschlak, Nelson, Wertheim, Gerald B, Jordan, Michael B, Cohen, Adam D, Krymskaya, Vera, Rubenstein, Arthur, Betts, Michael R, Kambayashi, Taku, van Rhee, Frits, Uldrick, Thomas S

Volltext

A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis von Sanchorawala, Vaishali, Palladini, Giovanni, Kukreti, Vishal, Zonder, Jeffrey A., Cohen, Adam D., Seldin, David C., Dispenzieri, Angela, Jaccard, Arnaud, Schönland, Stefan O., Berg, Deborah, Yang, Huyuan, Gupta, Neeraj, Hui, Ai-Min, Comenzo, Raymond L., Merlini, Giampaolo

Volltext

Antibody–drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study von Trudel, Suzanne, Lendvai, Nikoletta, Popat, Rakesh, Voorhees, Peter M., Reeves, Brandi, Libby, Edward N., Richardson, Paul G., Hoos, Axel, Gupta, Ira, Bragulat, Veronique, He, Zangdong, Opalinska, Joanna B., Cohen, Adam D.

Volltext

Writing About the Benefits of an Interpersonal Transgression Facilitates Forgiveness von McCullough, Michael E, Root, Lindsey M, Cohen, Adam D

Volltext

T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma von Garfall, Alfred L., Dancy, Ehren K., Cohen, Adam D., Hwang, Wei-Ting, Fraietta, Joseph A., Davis, Megan M., Levine, Bruce L., Siegel, Don L., Stadtmauer, Edward A., Vogl, Dan T., Waxman, Adam, Rapoport, Aaron P., Milone, Michael C., June, Carl H., Melenhorst, J. Joseph

Volltext

Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation von Cohen, Adam D, Schaer, David A, Liu, Cailian, Li, Yanyun, Hirschhorn-Cymmerman, Daniel, Kim, Soo Chong, Diab, Adi, Rizzuto, Gabrielle, Duan, Fei, Perales, Miguel A, Merghoub, Taha, Houghton, Alan N, Wolchok, Jedd D

Volltext

Combination immune therapies to enhance anti-tumor responses by NK cells von Mentlik James, Ashley, Cohen, Adam D, Campbell, Kerry S

Volltext

Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study von Huntington, Scott F, Dr, Weiss, Brendan M, MD, Vogl, Dan T, MD, Cohen, Adam D, MD, Garfall, Alfred L, MD, Mangan, Patricia A, CRNP, Doshi, Jalpa A, PhD, Stadtmauer, Edward A, Prof

Volltext

The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and -independent mechanisms von Pazina, Tatiana, James, Ashley M., MacFarlane, Alexander W., Bezman, Natalie A., Henning, Karla A., Bee, Christine, Graziano, Robert F., Robbins, Michael D., Cohen, Adam D., Campbell, Kerry S.

Volltext

Myeloma: next generation immunotherapy von Cohen, Adam D

Volltext

Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma von Jagannath, Sundar, Joseph, Nedra, Crivera, Concetta, Kharat, Akshay, Jackson, Carolyn C., Valluri, Satish, Cost, Patricia, Phelps, Hilary, Slowik, Rafal, Klein, Timothy, Smolen, Lee, Yu, Xueting, Cohen, Adam D.

Volltext

NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors von MacFarlane, Alexander W., Jillab, Mowafaq, Smith, Mitchell R., Alpaugh, R. Katherine, Cole, Marion E., Litwin, Samuel, Millenson, Michael M., Al-Saleem, Tahseen, Cohen, Adam D., Campbell, Kerry S.

Volltext

Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies von Cohen, Adam D., Garfall, Alfred L., Dogan, Ahmet, Lacey, Simon F., Martin, Chris, Lendvai, Nikoletta, Vogl, Dan T., Spear, Matthew, Lesokhin, Alexander M.

Volltext

Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up von Martin, Thomas, Usmani, Saad Z, Berdeja, Jesus G, Agha, Mounzer, Cohen, Adam D, Hari, Parameswaran, Avigan, David, Deol, Abhinav, Htut, Myo, Lesokhin, Alexander, Munshi, Nikhil C, O'Donnell, Elizabeth, Stewart, A Keith, Schecter, Jordan M, Goldberg, Jenna D, Jackson, Carolyn C, Yeh, Tzu-Min, Banerjee, Arnob, Allred, Alicia, Zudaire, Enrique, Deraedt, William, Olyslager, Yunsi, Zhou, Changwei, Pacaud, Lida, Madduri, Deepu, Jakubowiak, Andrzej, Lin, Yi, Jagannath, Sundar

Volltext

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a p... von Berdeja, Jesus G, Madduri, Deepu, Usmani, Saad Z, Jakubowiak, Andrzej, Agha, Mounzer, Cohen, Adam D, Stewart, A Keith, Hari, Parameswaran, Htut, Myo, Lesokhin, Alexander, Deol, Abhinav, Munshi, Nikhil C, O'Donnell, Elizabeth, Avigan, David, Singh, Indrajeet, Zudaire, Enrique, Yeh, Tzu-Min, Allred, Alicia J, Olyslager, Yunsi, Banerjee, Arnob, Jackson, Carolyn C, Goldberg, Jenna D, Schecter, Jordan M, Deraedt, William, Zhuang, Sen Hong, Infante, Jeffrey, Geng, Dong, Wu, Xiaoling, Carrasco-Alfonso, Marlene J, Akram, Muhammad, Hossain, Farah, Rizvi, Syed, Fan, Frank, Lin, Yi, Martin, Thomas, Jagannath, Sundar

Volltext

How to Train Your T Cells: Overcoming Immune Dysfunction in Multiple Myeloma von Cohen, Adam D, Raje, Noopur, Fowler, Jessica A, Mezzi, Khalid, Scott, Emma C, Dhodapkar, Madhav V

Volltext

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma von Shah, Nina, Aiello, Jack, Avigan, David E, Berdeja, Jesus G, Borrello, Ivan M, Chari, Ajai, Cohen, Adam D, Ganapathi, Karthik, Gray, Lissa, Green, Damian, Krishnan, Amrita, Lin, Yi, Manasanch, Elisabet, Munshi, Nikhil C, Nooka, Ajay K, Rapoport, Aaron P, Smith, Eric L, Vij, Ravi, Dhodapkar, Madhav

Volltext